Skip to main content
TipRanks
Go Ultimate75% OFF

Iwaki Co. Ltd. (6237) AI Stock Analysis

0 Followers
JP:6237

Iwaki Co. Ltd.

(TSE/TYO:6237)

Select Model
Rating:69Neutral
Price Target:JPY 4,243.00â–²(8.93% Upside)
Action:downgraded
Date:11/12/26

The company's excellent financial health, marked by a pristine balance sheet and solid profitability, is the primary strength driving the score. However, this is significantly offset by weak technicals, with the stock trading below key moving averages and showing strong negative momentum. The reasonable valuation provides a neutral-to-slightly-positive influence. The overall score reflects a fundamentally strong company currently facing bearish market sentiment.

Positive Factors
Sustained Revenue GrowthConsistent revenue expansion across five consecutive years indicates broadening demand for Iwaki’s fluid-handling and dosing equipment. Continued top-line growth can support operating scale, reinforce customer reach, and provide a durable foundation for earnings generation over the next several quarters.
Negative Factors
Uneven Cash ConversionUneven conversion of accounting earnings into cash makes the timing and reliability of internally generated funds less predictable. This can complicate capital allocation and reduce flexibility when working-capital movements or investment needs temporarily absorb operating profits.

Iwaki Co. Ltd. (6237) vs. iShares MSCI Japan ETF (EWJ)

-25%0%25%50%75%100%125%150%175%JP:6237+67.22%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 86.40B
Dividend Yield
2.23%
Average Volume (3M)
69.73K
Price to Earnings (P/E)
16.4
Beta (1Y)
1.45
Revenue Growth
13.01%
EPS Growth
28.70%
Country
Japan
Employees
1,146
Sector
General
Sector Strength
55
Industry
Industrial - Machinery

Iwaki Co. Ltd. Business Overview & Revenue Model

Company Description

Iwaki Co., Ltd. is a key player in the manufacturing and distribution of chemical fluid pumps and their corresponding control systems. The company primarily caters to Original Equipment Manufacturers (OEMs) across a broad spectrum of industries and a...

Iwaki Co. Ltd. Financial Statement Overview

Summary

Strong financial profile with consistent revenue growth (11% CAGR), improving margins, a rock-solid balance sheet (debt-to-equity <0.1), and robust cash flow generation. The overall financial health is excellent, though recent revenue growth moderation and uneven free cash flow conversion prevent a top-tier score.

Income Statement

85Very Positive

Balance Sheet

90Very Positive

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue47.69B47.69B45.76B44.54B37.73B32.44B
Gross Profit18.77B18.77B18.20B18.33B12.92B11.03B
EBITDA8.05B7.49B8.15B7.96B6.09B3.97B
Net Income4.84B4.84B4.47B4.46B4.26B2.40B
Balance Sheet
Total Assets55.84B55.84B54.15B49.10B45.25B38.45B
Cash, Cash Equivalents and Short-Term Investments9.98B9.98B8.88B8.39B8.93B8.78B
Total Debt4.06B4.06B2.76B2.72B2.73B2.08B
Total Liabilities14.36B14.36B16.04B15.58B16.38B13.20B
Stockholders Equity41.35B41.35B37.89B33.28B28.71B25.18B
Cash Flow
Free Cash Flow02.51B2.70B1.48B620.28M2.08B
Operating Cash Flow05.25B3.46B2.56B1.91B2.71B
Investing Cash Flow0-3.39B-784.01M-2.49B-1.52B-429.19M
Financing Cash Flow0-1.28B-1.88B-1.85B-419.04M-579.34M

Iwaki Co. Ltd. Technical Analysis

Technical Analysis SentimentNeutral
Last Price3895.00

Price Trends

50DMA3951.59Negative
100DMA4176.38Negative
200DMA3471.37Positive

Market Momentum

MACD-49.38Negative
RSI48.87Neutral
STOCH72.62Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6237, the sentiment is Neutral. The current price of 3895.00 is below the 20-day moving average (MA) of 3899.00, below the 50-day MA of 3951.59, and above the 200-day MA of 3471.37, indicating a neutral trend. The MACD of -49.38 indicates Negative momentum. The RSI at 48.87 is Neutral, neither overbought nor oversold. The STOCH value of 72.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:6237.

Iwaki Co. Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:6237 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:6363JP:636374OutperformJPY 65.66B6.05―2.59%-1.87%215.36%
JP:6237JP:623769NeutralJPY 85.32B16.44―2.23%13.01%28.70%
JP:6381JP:638167NeutralJPY 67.65B11.41―5.24%13.76%38.30%
JP:6393JP:639367NeutralJPY 12.26B8.81―5.02%0.61%3.85%
JP:6376JP:637665NeutralJPY 168.44B10.6810.86%1.88%12.76%63.89%
JP:6498JP:649864NeutralJPY 157.74B12.3310.55%3.36%14.51%10.65%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%50%100%150%JP:6237JP:6498JP:6376JP:6363JP:6381JP:6393Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:6237 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:6237Iwaki Co. Ltd.3895.001564.7667.15%
JP:6498Kitz Corporation1817.00185.4811.37%
JP:6376Nikkiso Co., Ltd.2759.001190.4175.89%
JP:6363Torishima Pump Mfg.Co., Ltd.2550.00710.5238.63%
JP:6381ANEST IWATA Corp.1700.00273.2819.15%
JP:6393Yuken Kogyo Co., Ltd.2989.00174.216.19%

Iwaki Co. Ltd. Corporate Events

Iwaki Revises Fiscal 2027 Earnings and Dividend Forecasts

Nov 11, 2026

Iwaki Co., Ltd., a Tokyo Stock Exchange Prime Market-listed company, reports sales in medical equipment, water treatment, and semiconductor/liquid crystal categories across Japan, the U.S., China, South Korea and Taiwan. It revised its fiscal 2027 fo...

Iwaki Adjusts and Completes Treasury Share Disposal for Employee Stock Plan

Sep 25, 2026

Iwaki Co., Ltd. has completed the disposal of treasury shares under a restricted stock incentive plan for its Employee Stock Ownership Association, following a resolution by its board in July 2026. The plan is designed to grant company shares to elig...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 12, 2026